United States · FDA National Drug Code directory
candesartan cilexetil and hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1326_2b38d778-d732-4a7b-bb34-b426a14e10bc
- Product NDC
- 70771-1326
- Form
- TABLET
- Composition / generic term
- candesartan cilexetil and hydrochlorothiazide
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180414
- Source listing expiry
- 20261231
Source-listed ingredients
- CANDESARTAN CILEXETIL — 32 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (70771-1326-0) · 70771-1326-0
- 100 TABLET in 1 BOTTLE (70771-1326-1) · 70771-1326-1
- 30 TABLET in 1 BOTTLE (70771-1326-3) · 70771-1326-3
- 10 BLISTER PACK in 1 CARTON (70771-1326-4) / 10 TABLET in 1 BLISTER PACK (70771-1326-2) · 70771-1326-4
- 90 TABLET in 1 BOTTLE (70771-1326-9) · 70771-1326-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →